• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N1-烷基化的3,4-二氢嘧啶-2(1H)-酮:便捷的一锅法选择性合成及其钙通道阻滞活性评估

N1-Alkylated 3,4-dihydropyrimidine-2(1H)-ones: Convenient one-pot selective synthesis and evaluation of their calcium channel blocking activity.

作者信息

Singh Kamaljit, Arora Divya, Poremsky Elizabeth, Lowery Jazmyne, Moreland Robert S

机构信息

Organic Synthesis Laboratory, Department of Applied Chemical Sciences and Technology, Guru Nanak Dev University, Amritsar 143 005, India.

出版信息

Eur J Med Chem. 2009 May;44(5):1997-2001. doi: 10.1016/j.ejmech.2008.10.002. Epub 2008 Oct 11.

DOI:10.1016/j.ejmech.2008.10.002
PMID:19008020
Abstract

It has been found that selective N1-alkylation of 3,4-dihydropyrimidine-2(1H)-ones can be achieved under solvent-less, mild phase transfer catalytic (PTC) conditions with tetrabutylammonium hydrogen sulfate and 50% aqueous NaOH as the catalyst and base, respectively. The procedure is tolerant to substitutional variation at key diversity points on the pyrimidinone moiety.

摘要

已发现,在无溶剂、温和的相转移催化(PTC)条件下,以硫酸氢四丁铵和50%的氢氧化钠水溶液分别作为催化剂和碱,可以实现3,4-二氢嘧啶-2(1H)-酮的选择性N1-烷基化。该方法对嘧啶酮部分关键多样性位点上的取代变化具有耐受性。

相似文献

1
N1-Alkylated 3,4-dihydropyrimidine-2(1H)-ones: Convenient one-pot selective synthesis and evaluation of their calcium channel blocking activity.N1-烷基化的3,4-二氢嘧啶-2(1H)-酮:便捷的一锅法选择性合成及其钙通道阻滞活性评估
Eur J Med Chem. 2009 May;44(5):1997-2001. doi: 10.1016/j.ejmech.2008.10.002. Epub 2008 Oct 11.
2
Regioselective N1-alkylation of 3,4-dihydropyrimidine-2(1H)-ones: screening of their biological activities against Ca(2+)-ATPase.3,4-二氢嘧啶-2(1H)-酮的 N1 区域选择性烷基化:对其抑制 Ca(2+)-ATP 酶的生物活性进行筛选。
Eur J Med Chem. 2012 Aug;54:223-31. doi: 10.1016/j.ejmech.2012.04.043. Epub 2012 May 16.
3
One-pot synthesis of 3,4-dihydropyrimidin-2(1H)-ones using chloroacetic acid as catalyst.以氯乙酸为催化剂一锅法合成3,4-二氢嘧啶-2(1H)-酮
Bioorg Med Chem Lett. 2007 Jun 15;17(12):3508-10. doi: 10.1016/j.bmcl.2006.12.068. Epub 2006 Dec 23.
4
Highly regioselective synthesis of N-3 organophosphorous derivatives of 3,4-dihydropyrimidin-2(1H)-ones and their calcium channel binding studies.高区域选择性合成 3,4-二氢嘧啶-2(1H)-酮的 N-3 有机膦衍生物及其钙通道结合研究。
Eur J Med Chem. 2012 Aug;54:397-402. doi: 10.1016/j.ejmech.2012.05.017. Epub 2012 May 26.
5
Studies on the synthesis and biological activitiy of 6-ethyl-4-aryl-5-methoxycarbonyl-3,4-dihydropyrimidin-2(1H)-ones.6-乙基-4-芳基-5-甲氧基羰基-3,4-二氢嘧啶-2(1H)-酮的合成与生物活性研究
Arzneimittelforschung. 2007;57(3):137-42. doi: 10.1055/s-0031-1296596.
6
Water-tolerant and reusable Lewis acid catalyst for the one-pot synthesis of 3,4-dihydropyrimidin-2-(1H)-ones under solvent-free conditions.无溶剂条件下一锅法合成 3,4-二氢嘧啶-2(1H)-酮的耐水性和可重复使用的路易斯酸催化剂。
Prep Biochem Biotechnol. 2010;40(2):101-6. doi: 10.1080/10826060903558562.
7
Diversification of a thieno[2,3-d]pyrimidin-4-one scaffold via regioselective alkylation reactions.通过区域选择性烷基化反应实现噻吩并[2,3-d]嘧啶-4-酮骨架的多样化。
J Comb Chem. 2009 May-Jun;11(3):508-14. doi: 10.1021/cc9000373.
8
Phase-transfer-catalyzed alkylation of guanidines by alkyl halides under biphasic conditions: a convenient protocol for the synthesis of highly functionalized guanidines.双相条件下卤代烷烃通过相转移催化的胍烷基化反应:一种合成高官能化胍的简便方法。
J Org Chem. 2003 Mar 21;68(6):2300-9. doi: 10.1021/jo0265535.
9
Direct one-pot conversion of acylated carbohydrates into their alkylated derivatives under heterogeneous reaction conditions using solid NaOH and a phase transfer catalyst.在非均相反应条件下,使用固体氢氧化钠和相转移催化剂将酰化碳水化合物直接一锅法转化为其烷基化衍生物。
Carbohydr Res. 2005 May 23;340(7):1373-7. doi: 10.1016/j.carres.2005.03.007.
10
One-pot synthesis of 3,4-dihydropyrimidin-2(1H)-ones using CuBr2 as catalyst.以溴化铜为催化剂一锅法合成3,4-二氢嘧啶-2(1H)-酮
Prep Biochem Biotechnol. 2006;36(4):375-81. doi: 10.1080/10826060600912682.

引用本文的文献

1
Synthesis of 3,4-Dihydropyrimidin(thio)one Containing Scaffold: Biginelli-like Reactions.含3,4-二氢嘧啶(硫)酮骨架的合成:类Biginelli反应
Pharmaceuticals (Basel). 2022 Jul 30;15(8):948. doi: 10.3390/ph15080948.
2
Synthesis, Characterization, and Anticancer Activities Evaluation of Compounds Derived from 3,4-Dihydropyrimidin-2(1)-one.3,4-二氢嘧啶-2(1H)-酮衍生化合物的合成、表征及抗癌活性评价。
Molecules. 2019 Mar 3;24(5):891. doi: 10.3390/molecules24050891.
3
Effect of N-1 arylation of monastrol on kinesin Eg5 inhibition in glioma cell lines.
莫那可尔N-1芳基化对胶质瘤细胞系中驱动蛋白Eg5抑制作用的影响。
Medchemcomm. 2018 Apr 17;9(6):995-1010. doi: 10.1039/c8md00095f. eCollection 2018 Jun 1.
4
Recent developments in the synthesis and applications of dihydropyrimidin-2(1H)-ones and thiones.二氢嘧啶-2(1H)-酮和硫酮的合成与应用的最新进展。
Mol Divers. 2018 May;22(2):405-446. doi: 10.1007/s11030-017-9806-z. Epub 2018 Jan 18.
5
An Efficient, Eco-friendly and Sustainable One-Pot Synthesis of 3,4-Dihydropyrimidin-2(1H)-ones Directly from Alcohols Catalyzed by Heteropolyanion-Based Ionic Liquids.杂多阴离子基离子液体催化醇直接一锅法高效、环保、可持续合成 3,4-二氢嘧啶-2(1H)-酮。
Molecules. 2017 Sep 11;22(9):1531. doi: 10.3390/molecules22091531.
6
Crystal structures of 2-[(4,6-di-amino-pyrimidin-2-yl)sulfan-yl]--(2,4-di-methyl-phen-yl)acetamide and 2-[(4,6-di-amino-pyrimidin-2-yl)sulfan-yl]--(3-meth-oxy-phen-yl)acetamide.2-[(4,6-二氨基嘧啶-2-基)硫烷基]-(2,4-二甲基苯基)乙酰胺和2-[(4,6-二氨基嘧啶-2-基)硫烷基]-(3-甲氧基苯基)乙酰胺的晶体结构
Acta Crystallogr E Crystallogr Commun. 2017 Jun 13;73(Pt 7):996-1000. doi: 10.1107/S2056989017008143. eCollection 2017 Jul 1.
7
An efficacious protocol for C-4 substituted 3,4-dihydropyrimidinones. Synthesis and calcium channel binding studies.一种用于C-4取代的3,4-二氢嘧啶酮的有效方案。合成及钙通道结合研究。
European J Org Chem. 2009 Jul 1;2009(19). doi: 10.1002/ejoc.200900208.
8
Synthesis, characterization and biological evaluation of dihydropyrimidine derivatives.二氢嘧啶衍生物的合成、表征及生物评价。
Saudi Pharm J. 2012 Jan;20(1):75-9. doi: 10.1016/j.jsps.2011.04.002. Epub 2011 Apr 23.
9
Gold catalyzed cyclization of alkyne-tethered dihydropyrimidones.金催化炔键连接的二氢嘧啶酮环化反应。
Org Lett. 2011 Aug 19;13(16):4228-31. doi: 10.1021/ol2015658. Epub 2011 Jul 13.